<?xml version="1.0" encoding="UTF-8"?>
<GaPExchange xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:noNamespaceSchemaLocation="./dbGaPEx2.1.5.xsd">

<MetaVariables>
	<Submitter/>
	<Method/>
</MetaVariables>
<MetaLinks/>

<Projects>
	<Project/>
</Projects>

<Studies>

<Study source="dbGaP" accession="phs000666.v1.p1" parentStudy="phs000666.v1.p1" createDate="2013-09-27" modDate="2013-09-30">

<Configuration>
	<Data_Provider><![CDATA[
		<table border="1">
		<tr><th>Title</th><th>Name</th><th>Institute</th></tr>
		<tr><td>Principal Investigator</td><td>Scott D. Boyd, MD, PhD</td><td>Stanford University, Stanford, CA, USA</td></tr>
		<tr><td>Funding Source</td><td>U19AI090019</td><td>National Institutes of Health, Bethesda, MD, USA</td></tr>
		<tr><td>Funding Source</td><td>AG-NS-792-11</td><td>The Ellison Medical Foundation, New York, NY, USA</td></tr>
		</table>
	]]></Data_Provider>
	<StudyNameEntrez>B and T Cell Determinants of Influenza Vaccine Responses in the Elderly</StudyNameEntrez>
	<StudyNameReportPage>B and T Cell Determinants of Influenza Vaccine Responses in the Elderly</StudyNameReportPage>
	<StudyTypes>
		<StudyType>Longitudinal</StudyType>
	</StudyTypes>
	<Description><![CDATA[
<p>The study sequenced antibody heavy chain gene rearrangements from human subjects receiving influenza vaccination.</p>]]>
	</Description>
	<StudyInEx><![CDATA[
<p><b>Inclusion:</b> <ul> <li>Age 18-30, 60-79, or 80-100 years, inclusive at time of initial enrollment</li> <li>General good health and ambulatory at time of enrollment</li> <li>No acute illness at time of vaccination</li> <li>Willing and able to sign Informed Consent</li> <li>Available for follow-up for the planned duration of the study</li> <li>Acceptable medical history by screening evaluation and brief clinical assessment</li> <li>All female subjects of childbearing potential must use an acceptable method of contraception and not become pregnant for the duration of the clinical phase of the study</li> </ul> </p> <p><b>Exclusion:</b> <ul> <li>Off-study vaccination during the period of the study</li> <li>Allergy to egg or egg products</li> <li>Allergy to vaccine components, including thimerosal</li> <li>Active systemic or serious concurrent illness, including febrile illness on the day of vaccination</li> <li>History of immunodeficiency</li> <li>Any chronic disorder which, in the opinion of the investigator, might jeopardize volunteer safety or compliance with the protocol.</li> <li>Blood pressure &gt; 150 systolic or &gt; 95 diastolic at Visit 1</li> <li>Chronic Hepatitis B or C</li> <li>Recent or current use of systemic immunosuppressive medication, including glucocorticoids (corticosteroid nasal sprays and inhaled steroids are permissible). Use of oral steroids (&lt; 20mg predisone - equivalent/day) may be acceptable after review by the investigator.</li> <li>Autoimmune disease </li> <li>History of blood dyscrasias or hemoglobinopathies requiring regular medical follow up or hospitalization during the preceding year</li> <li>Use of anti-coagulation medication such as Coumadin or Lovenox, or anti-platelet agents such as aspirin, Plavix, Aggrenox must be reviewed by investigator to determine if this would affect the volunteer&#39;s safety.</li> <li>Receipt of blood or blood products within the past 6 months </li> <li>Medical or psychiatric condition or occupational responsibilities that preclude subject compliance with the protocol</li> <li>Receipt of inactivated vaccine within 14 days prior to vaccination</li> <li>Receipt of live, attenuated vaccine within 60 days of vaccination</li> <li>History of Guillain-Barr&#233; Syndrome</li> <li>Pregnant or lactating woman</li> <li>Use of investigational agents within 30 days prior to enrollment</li> <li>Donation of the equivalent of a unit of blood within 6 weeks prior to enrollment</li> <li>Any condition which, in the opinion of the investigator, might interfere with volunteer safety, study objectives or the ability of the participant to understand or comply with the study protocol.</li> </ul> </p>]]>
	</StudyInEx>
	<StudyProjects>
		<Project/>
	</StudyProjects>
	<Publications>
		<Publication>
			<Journal authors="Wang C, et al." title="Effects of aging, CMV infection and EBV infection on human B cell repertoires" journal="Journal of Immunology. 2013. Submitted."/>
		</Publication>
	</Publications>
	<Diseases>
		<Disease vocab_source="MESH" vocab_term="Influenza Vaccines"/>
		<Disease vocab_source="MESH" vocab_term="Aged"/>
	</Diseases>
	<Attributions>
		<Header title="Principal Investigator">
			<AttName>Scott D. Boyd, MD, PhD</AttName>
			<Institution>Stanford University, Stanford, CA, USA</Institution>
		</Header>
		<Header title="Funding Source">
			<AttName>U19AI090019</AttName>
			<Institution>National Institutes of Health, Bethesda, MD, USA</Institution>
		</Header>
		<Header title="Funding Source">
			<AttName>AG-NS-792-11</AttName>
			<Institution>The Ellison Medical Foundation, New York, NY, USA</Institution>
		</Header>
	</Attributions>
	<DisplayPublicSummary>yes</DisplayPublicSummary>
	<ConsentGroups>
		<ConsentGroup groupNum="1" shortName="DS-IR-IRB" longName="Disease-Specific (Immunological Research, IRB)"/>
	</ConsentGroups>
</Configuration>

  <AuthorizedAccess>
    <DacInfo ssDacId="0">
      <DacName>NIAID</DacName>
      <DacFullName>NIAID DAC</DacFullName>
      <DacEmail>0</DacEmail>
      <DacPhone></DacPhone>
      <DacUrl></DacUrl>
    </DacInfo>
    <Policy Policy_ID="phs000666.v1.p1_policy" ref_ssDacId="0">
      <DisplayResearchStatement>yes</DisplayResearchStatement>
      <DisplayPublicSummary>yes</DisplayPublicSummary>
      <EmbargoLength>12</EmbargoLength>
      <YearsUntilRenewal>1</YearsUntilRenewal>
      <WeeksCancelRequest>8</WeeksCancelRequest>
      <PdfSupplementReqired>yes</PdfSupplementReqired>
      <AcknowledgementText>
        <para>
          http://dbgap.ncbi.nlm.nih.gov/aa/wga.cgi?page=DUC&amp;view_pdf&amp;stacc=phs000666.v1.p1
        </para>
      </AcknowledgementText>
      <DocumentSet>
        <DataUseCertificate Label="Data Use Certificate" FilePath="https://dbgap.ncbi.nlm.nih.gov/aa/wga.cgi?page=DUC&amp;view_pdf&amp;stacc=phs000666.v1.p1" FileName="Boyd_DUC.pdf"/>
      </DocumentSet>
    </Policy>
    <ConsentGroups>
      <ParticipantSet groupNum-REF="1">
        <ConsentName>Disease-Specific (Immunological Research, IRB)</ConsentName>
        <ConsentAbbrev>DS-IR-IRB</ConsentAbbrev>
        <UseLimitation>Use of the data must be related to Immunological Research.
Requestor must provide documentation of local IRB approval.</UseLimitation>
        <IrbRequired>Yes</IrbRequired>
      </ParticipantSet>
    </ConsentGroups>
  </AuthorizedAccess>


</Study>

</Studies>

</GaPExchange>
